PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
21.62%
Revenue growth at 50-75% of ACB.TO's 41.84%. Martin Whitman would worry about competitiveness or product relevance.
39.20%
Positive gross profit growth while ACB.TO is negative. John Neff would see a clear operational edge over the competitor.
-255.04%
Negative EBIT growth while ACB.TO is at 141.18%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-255.04%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
102.01%
Net income growth at 75-90% of ACB.TO's 116.91%. Bill Ackman would press for improvements to catch or surpass competitor performance.
60.99%
EPS growth at 50-75% of ACB.TO's 102.59%. Martin Whitman would suspect a lag in operational efficiency or a higher share count.
101.35%
Similar diluted EPS growth to ACB.TO's 102.59%. Walter Schloss might see standard sector or cyclical influences on both firms.
16.05%
Share count expansion well above ACB.TO's 6.89%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
14.82%
Diluted share count expanding well above ACB.TO's 8.08%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-96.29%
Negative OCF growth while ACB.TO is at 23.70%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-212.61%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
6217.76%
3Y CAGR of 6217.76% while ACB.TO is zero. Bruce Berkowitz would see if small gains can accelerate to a more decisive lead.
103.53%
Positive long-term OCF/share growth while ACB.TO is negative. John Neff would see a structural advantage in sustained cash generation.
112.04%
Positive OCF/share growth while ACB.TO is negative. John Neff might see a comparative advantage in operational cash viability.
102.33%
3Y OCF/share CAGR above 1.5x ACB.TO's 61.10%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
387.66%
Net income/share CAGR above 1.5x ACB.TO's 248.02% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
2084.63%
5Y net income/share CAGR above 1.5x ACB.TO's 561.56%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
232.29%
3Y net income/share CAGR above 1.5x ACB.TO's 117.82%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
2867.95%
10Y equity/share CAGR above 1.5x ACB.TO's 826.92%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
4806.10%
5Y equity/share CAGR above 1.5x ACB.TO's 2459.99%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
1601.21%
3Y equity/share CAGR similar to ACB.TO's 1483.19%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
830.66%
Our AR growth while ACB.TO is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
36.09%
Inventory growth well above ACB.TO's 19.42%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
95.84%
Asset growth at 75-90% of ACB.TO's 110.56%. Bill Ackman suggests reviewing opportunities to match or surpass the competitor's asset expansion if profitable.
66.82%
50-75% of ACB.TO's 112.23%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
19.54%
We have some new debt while ACB.TO reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
38.52%
R&D growth drastically higher vs. ACB.TO's 60.75%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
69.20%
SG&A growth well above ACB.TO's 120.40%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.